Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
0.00% | 3 | |
+10.79% | 116B | |
+11.65% | 106B | |
-6.20% | 23.89B | |
-2.97% | 21.58B | |
-11.00% | 18.96B | |
-13.41% | 16.33B | |
-40.50% | 16.96B | |
+6.64% | 14.14B | |
+31.84% | 12.02B |
- Stock Market
- Equities
- NBRVF Stock
- News Nabriva Therapeutics plc
- Transcript : Nabriva Therapeutics plc Presents at BofA Securities 2020 Health Care Conference, May-13-2020 11